First dual-protection intravaginal ring design shows promise in long-term HIV, pregnancy prevention
Wednesday, November 13, 2013 - 11:00
in Health & Medicine
A new intravaginal ring has been developed for the sustained 90-day co-delivery of tenofovir and levonorgestrel, an anti-human immunodeficiency virus (HIV) drug and a contraceptive. Tenofovir is the only topical prophylactic shown to be effective at reducing the sexual transmission of HIV when formulated in a gel.